
Overview
Megan R. Haymart, MD is Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology, and Diabetes at the University of Michigan. She holds the Nancy Wigginton Endocrinology Research Professorship of Thyroid Cancer and is Director of Thyroid Cancer Research at the University of Michigan. Dr. Haymart received her medical degree at Johns Hopkins University School of Medicine and completed her internal medicine residency at Johns Hopkins Hospital. She then completed a fellowship in endocrinology, diabetes, and metabolism at the University of Wisconsin. She has been faculty at the University of Michigan since 2009.Dr. Haymart has a history of NIH-funded research focused on optimizing thyroid care delivery. She is a health services researcher who primarily studies thyroid cancer care across the disease continuum: from the diagnosis of a thyroid nodule to cancer survivorship. In recognition of her research, she received the American Thyroid Association’s Van Meter Award for outstanding contributions to research on the thyroid gland (2017), the University of Michigan’s Jerome Conn Award for Research Excellence (2017), membership to American Society for Clinical Investigation (2018), the AACE Hossein Gharib Education Lectureship Award for exemplary contributions to an individual profession or area of expertise (2021), and the inaugural AACE Endocrine Care Innovation Award in recognition of her team’s outstanding body of work focused on clinical outcomes or health care delivery (2025).Dr. Haymart is actively involved in improving research infrastructure at the University of Michigan. This includes her roles as Assistant Director of Data Solutions for AI & Digital Health Innovation, faculty support for MICHR, and co-Director of Patient’s First. She also devotes time to mentoring junior faculty and trainees resulting in her receipt of the MICHR Distinguished Clinical and Translational Research Mentor Award (2021) and the Women in Thyroidology and American Thyroid Association Woman of the Year Award (2021) for promoting the advancement of women, both within the organization and field.
Dr. Haymart is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Thyroid Nodule, Papillary Thyroid Cancer, Thyroidectomy, and Hormone Replacement Therapy (HRT).
Dr. Haymart is board certified in Endocrinology, Diabetes & Metabolism. She is actively involved in clinical research, co-authoring 129 peer reviewed articles.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MEDICARE MAPD
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
24 Frank Lloyd Wright Dr Ste 1300, Lobby C, Ann Arbor, MI 48105
1500 E Medical Center Dr, Floor B1 Reception A, Ann Arbor, MI 48109
Additional Areas of Focus
Dr. Haymart has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Domino's Farms
Dr. Richard Auchus is a professor of Internal Medicine, Division of Metabolism, Endocrinology & Diabetes (MEND) and Chief of the Endocrinology & Metabolism Section at the Ann Arbor VA Medical Center. He received his medical degree and Ph.D. in pharmacology from Washington University in St. Louis. Then Dr. Auchus completed a residency at the University of Iowa and an endocrinology fellowship at UTHSC-San Antonio/Wilford Hall Medical Center. Dr. Auchus came to UMHS from the Graduate School of Biomedical Sciences in Southwestern Medical School, University of Texas, where he was a Professor of Internal Medicine - Endocrinology.Dr. Auchus is a steroid biologist with expertise both in basic science and clinical/translational science. His work has included translational research into: molecular and genetic mechanisms of human hypertension, improved diagnostic studies and management in primary aldosteronism and Cushing syndromes, modifier genes in 21-hydroxylase deficiency, cardiovascular disease in polycystic ovary syndrome, and the endocrinology of traumatic brain injury. Dr. Auchus is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Congenital Adrenal Hyperplasia (CAH), Intersex, Cushing's syndrome, Hormone Replacement Therapy (HRT), and Orchiectomy. Dr. Auchus is board certified in Endocrinology, Diabetes & Metabolism.
Rogel Cancer Center
Dr. Else’s primary appointment is with the Division of Metabolism, Endocrinology and Diabetes. He received his MD degree from the University of Hamburg, Germany. He pursued his clinical training at the University of Hamburg (Residency: Internal Medicine) and the University of Michigan (Residency: Internal Medicine, Fellowship: Endocrinology). His main research interests are the genetics of endocrine tumors. Dr. Else’s clinical practice focuses on the care for patients with benign and malignant endocrine tumors, particularly pheochromocytoma, adrenocortical tumors and neuroendocrine tumors as well as accompanying hormone excess syndromes (e.g Cushing syndrome, primary aldosteronism). Dr. Else has a particular interest in taking care of patients with hereditary syndromes that predispose to the development of endocrine tumors (e.g. Multiple Endocrine Neoplasia (MEN) type 1, MEN2A & MEN2B, Hereditary Paraganglioma Syndrome). He attends the Multidisciplinary Endocrine Oncology Clinic, where patients with tumors receive diagnostic procedures and treatment. In addition he is part of the Cancer Genetics Clinic, which evaluates patients for hereditary syndromes and also facilitates regular exams and surveillance for patients at risk for endocrine tumors. Dr. Else is highly rated in 105 conditions, according to our data. His clinical expertise encompasses Adrenal Cancer, Adrenocortical Carcinoma, Adrenal Gland Adenoma, Neuroendocrine Tumor, and Thyroidectomy. Dr. Else is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.
Rogel Cancer Center
Dr. Adina Turcu completed her Internal Medicine residency at Norwalk Hospital/Yale University, CT, where she also served a year as Chief Resident. She completed her Endocrinology fellowship at Mayo Clinic, Rochester, MN, where she was the recipient of the Randall G. Sprague Award for outstanding clinical, investigative, and academic achievement in Endocrinology.Dr. Turcu pursued a postdoctoral fellowship at the University of Michigan, prior to joining the UoM faculty team in the Division of Metabolism, Endocrinology & Diabetes. Her research work focuses on adrenal disorders, including congenital adrenal hyperplasia, Cushing’s syndrome, primary aldosteronism, and pheochromocytoma/paraganglioma. Dr. Turcu is highly rated in 24 conditions, according to our data. Her clinical expertise encompasses Hyperaldosteronism, Congenital Adrenal Hyperplasia (CAH), Adrenal Gland Adenoma, Ovarian Overproduction of Androgens, and Hormone Replacement Therapy (HRT). Dr. Turcu is board certified in Endocrinology, Diabetes & Metabolism.
Frequently Asked Questions about Dr. Megan R. Haymart
How do I make an appointment with Dr. Megan R. Haymart?
You can book an appointment with Dr. Megan R. Haymart by calling their office at 866-266-5221. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Megan R. Haymart a top-rated expert for Thyroid Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Megan R. Haymart is classified as an Elite expert for Thyroid Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Megan R. Haymart specialize in?
While Dr. Megan R. Haymart is a Endocrinology, they have specific expertise in Thyroid Cancer, Thyroid Nodule, and Papillary Thyroid Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Endocrinology.
Does Dr. Megan R. Haymart participate in research or clinical trials?
Yes. Dr. Megan R. Haymart has published 129 articles and abstracts on conditions like Thyroid Cancer. You can view a list of Dr. Megan R. Haymart's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Megan R. Haymart accept my insurance?
Dr. Megan R. Haymart accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 866-266-5221 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Thyroid CancerDr. Haymart isElite. Learn about Thyroid Cancer.
- Thyroid NoduleDr. Haymart isElite. Learn about Thyroid Nodule.
- Distinguished
- Anaplastic Thyroid CancerDr. Haymart isDistinguished. Learn about Anaplastic Thyroid Cancer.
- Follicular Thyroid CancerDr. Haymart isDistinguished. Learn about Follicular Thyroid Cancer.
- Papillary Thyroid CancerDr. Haymart isDistinguished. Learn about Papillary Thyroid Cancer.
- Advanced
- HypothyroidismDr. Haymart isAdvanced. Learn about Hypothyroidism.
- Medullary Thyroid CarcinomaDr. Haymart isAdvanced. Learn about Medullary Thyroid Carcinoma.
- Multiple Endocrine NeoplasiaDr. Haymart isAdvanced. Learn about Multiple Endocrine Neoplasia.
- Multiple Endocrine Neoplasia Type 2Dr. Haymart isAdvanced. Learn about Multiple Endocrine Neoplasia Type 2.
- ThyroidectomyDr. Haymart isAdvanced. Learn about Thyroidectomy.
- Experienced
- Addison's DiseaseDr. Haymart isExperienced. Learn about Addison's Disease.
- Adrenal Insufficiency PediatricDr. Haymart isExperienced. Learn about Adrenal Insufficiency Pediatric.
- Autosomal Dominant HypocalcemiaDr. Haymart isExperienced. Learn about Autosomal Dominant Hypocalcemia.
- Familial Glucocorticoid DeficiencyDr. Haymart isExperienced. Learn about Familial Glucocorticoid Deficiency.
- Familial Hypocalciuric Hypercalcemia Type 1
- Glucocorticoid ResistanceDr. Haymart isExperienced. Learn about Glucocorticoid Resistance.

